Alzheimer's Disease International (ADI)
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Lecanemab is the first therapy of its kind approved in the EU that could potentially slow the progression of Alzheimer’s disease. The use of lecanemab will now be considered by national payers, who will assess the treatment against further nationally determined criteria.
This comes as the Appeals board of the European Commission were unable to reach a verdict following the “no opinion” decision of the Standing Committee on Medicinal Products for Human Use and the European Commission. The matter will now be referred the European Commission for a final decision.
DY Suharya, ADI’s Regional Director for Asia Pacific, attended the 2024 World Innovation Summit for Health (WISH) in Doha, Qatar, where over 3,000 global health leaders gathered to explore innovative solutions under the theme “Humanizing Health: Conflict, Equity, and Resilience.”. In this blog, we highlight DY’s highlights from this bi-annual event, including a plenary sessions delivered by Dame Louise Robinson, Co-Chair of the ADI Medical and Scientific Advisory Panel (MSAP) and Director Institute of Ageing, Newcastle University, UK.
ADI Member, Dementia Australia highlights the launch of their new blog podcast ‘Hold the Moment’ developed by people living with dementia, aiming to reduce isolation and loneliness felt by carers and people living with dementia.
At the Istituto Superiore di Sanità’s 17th Conference on ‘The Contribution of Centres for Cognitive Disorders and Dementia Centres in the Integrated Management of Patients' in Italy. ADI CEO, Paola Barbarino highlighted progress made on dementia globally as well as nationally, calling for greater resources and funding for dementia in Italy.
ADI team members from across the globe met up in Xi'an China in late October 2024 for the 27th Asia-Pacific Region Conference of Alzheimer’s Disease International and the 2024 Annual Conference of Alzheimer’s Disease Chinese. This blog showcases highlights from the conferences and the ADI Asia Pacific regional meeting.
The creation of the World Alzheimer Report is always a dynamic and collaborative process. This year’s report is a follow-up to the 2019 World Alzheimer Report on attitudes to dementia, and like five years ago, ADI commissioned the London School of Economics’ Care Policy and Evaluation Centre The survey and report aimed to track changes in global perceptions of dementia, while adding new questions around treatments and policy impact. Hear from ADI’s Publications Manager Chloé Benoist about how the team brought this year’s report together.
In October, ADI engaged in crucial discussions and events across Europe, emphasizing the importance of addressing dementia as a public health priority through innovative strategies and global collaboration.
In a regional push for improved dementia support, Kazakhstan's first Dementia Awareness Day highlights the progress being made across Central and Western Asia. In this blog we spotlight the work being undertaken in the region.
ADI is sharing a snapshot of the Asia Pacific region’s activities during World Alzheimer’s Month this year. From memory walks, to dementia screenings, to concerts, ADI has been delighted to see such a broad variety of activities dedicated to raising awareness of dementia in the region. With opening words from ADI’s Regional Director for Asia Pacific, we are reporting the multiple actions and efforts that have been taken across the region.